Ahmedabad based Cadila Pharmaceuticals has on-boarded V.K Singh as Chief Operating Officer of its Chemical Strategic Business Unit, which mainly focuses on Active Pharma Ingredients (APIs) manufactured in India. Mr Singh brings experience of over 20 years in the Pharma industry and will be based out of Ahmedabad.
V.K. Singh was last associated as Chief Business Officer with Strides Pharma Science and has experience in formulations, drug delivery, APIs, business development, corporate strategy and mergers and acquisitions. Prior to Strides, he was associated with pharma companies such as Emcure Pharmaceuticals, RPG Life Sciences, Ethypharm India, and Ranbaxy in various roles.
“Cadila Pharmaceuticals is one of the fastest-growing pharma companies in the country and is at an inflection point in its growth trajectory. I am excited about being part of this journey. I look forward to working closely with the team at Cadila Pharmaceuticals to chart out new growth opportunities,” Mr. Singh said on the association with the company.
Over the last six decades, Cadila Pharmaceuticals has been engaged in the development and manufacturing of medicines and in making them available for patients across the world. Company’s operations include manufacturing a wide range of products from biotechnology products, finished formulations, pharma machinery, API’s – Intermediates and OTC food supplements.
–AK
HrNxt.com Newsdesk has researchers and writers with an excellent domain knowledge about the talent ecosystem, and the business environment. The team keeps a tab on the latest happenings in the ecosystem to bring most relevant news and insights for our readers. You can connect with our newsdesk at newsdesk@hrnxt.com.